AR and neoplasm: By further research on the pathogenesis of CRPC, it is found that AR available to drive tumor progression is still the key factor to promote the occurrence and development of CRPC, therefore, androgen deprivation therapy remains the basic means to control the occurrence and development of CRPC [56].